Blood cancer patients in England first in world [not including Scotland] to be offered ‘Trojan horse’ drug
Professor John Robertson OBA, former Faculty Research Ethics Chair It’s kind of sad that when I see headlines like the one above, in the Guardian today, I immediately think: Did they bother checking NHS Scotland? When they say ‘England’, do they mean ‘UK?’ There’s no mention of Scotland in the report, but not for the first time, I find something that shows their habitual Anglocentrism. From Myeloma UK, undated but posted in March 2025: Approval – the licensed treatment is approved for general use on the NHS. Approval is based on clinical effectiveness and cost-effectiveness. Two of the appraisal bodies … Continue reading Blood cancer patients in England first in world [not including Scotland] to be offered ‘Trojan horse’ drug
